Please leave this field empty
Facebook Twitter YouTube

Accordia Board of Directors

Our board of directors brings a wealth of experience and knowledge, providing strategic guidance and strong governance.

Officers

Henry A. McKinnell, Jr., PhD
Chair of the Board of Directors of Accordia Global Health Foundation

Warner C. Greene, MD, PhD
Executive Chair of Accordia Global Health Foundation

Nelson Sewankambo, MD
Vice President

Robert Mallett
Treasurer

Suzanne Sande Mrlik
Secretary

Board Members

Nicole K. Bates, DrPH.
Deputy Director, Global Policy & Advocacy, Bill & Melinda Gates Foundation

Katherine States Burke
Global Health Advocate

Gary M. Cohen, MBA
Executive Vice President, BD

Joseph M. Feczko, MD
(Retired) Senior Vice President & Chief Medical Officer, Pfizer Inc

Julie L. Gerberding, MD, MPH
President, Merck Vaccines

Ambassador Eric P. Goosby, MD
Professor of Medicine in the Global Health Sciences program, University of California, San Francisco

Warner C. Greene, MD, PhD
Director, Gladstone Institute of Virology and Immunology, Nick and Sue Hellman Distinguished Professor of Translational Medicine; Professor of Medicine, Microbiology and Immunology; University of California, San Francisco

Donald A. Holzworth, MS
Executive in Residence, University of North Carolina Gillings School of Global Public Health

Robert Mallett
Former healthcare senior executive at Pfizer Inc and United Healthcare

Henry A. McKinnell, Jr., PhD
(Retired) Chairman and CEO, Pfizer Inc

Suzanne Sande Mrlik
Global Health Advocate

Fred Port, MBA
(Retired) Director of Callaway Golf and President of Callaway Golf International

Steve Sinacore
Co-Founder and Principal of Atrevida Partners, LLC 

Senior Advisors to the Board

David Greeley
Global Health Advocate

Nicole K. Bates, DrPH.

Dr. Nicole Bates leads the global advocacy and communications strategies for polio eradication, vaccines and child health at the Bill & Melinda Gates Foundation. Through these strategies, the foundation has leveraged its investments resulting in $8.3 billion to deliver lifesaving vaccines and other critical interventions to children in the world’s poorest countries.   

Prior to joining the foundation, Bates served as the Director for Government Relations at the Global Health Council and worked in the U.S. Senate on domestic health and social issues for Senator Edward M. Kennedy (D-MA). She began her career in the Chronic Disease Center at the Centers for Disease Control and Prevention (CDC) as a Presidential Management Fellow.  

Bates earned a Doctorate of Public Health and Master's of Public Health from the University of North Carolina at Chapel Hill. She completed her undergraduate work with high honors from the University of Virginia

Back to top  

Katherine States Burke, M.M., MSc.  

Katherine Burke is a graduate of Harvard College, Northwestern’s Kellogg School of Management, and UCSF. After a first career in journalism, she turned to global health education and advocacy. Her two primary research interests are centers of excellence as a means of capacity building and online education and its potential in low-resource settings. She lives in San Francisco with her husband and three sons.

 

Back to top  

Gary M. Cohen, MBA  Gary M. Cohen

Gary Cohen is executive vice president of BD (Becton, Dickinson and Company), a global medical technology company with 30,000 associates in over 50 countries.  He also serves as acting CEO of GBCHealth, board chair of the CDC Foundation, vice chair of the UN Special Envoy’s Office for MDG Financing and for Malaria, and a board director of the Perrigo Company, US Fund for UNICEF and Accordia Global Health Foundation, and an advisor to the Clinton Global Initiative.  He recently served as a United Nations Commissioner on Life Saving Commodities for Women and Children.  Cohen and BD are engaged across the public, private and NGO sectors to address health needs in developing countries.  He has been an advocate and speaker on global health, child immunization, HIV/AIDS and health system strengthening in the UN, World Bank, World Economic Forum, US Department of State and Council on Foreign Relations.  

Cohen founded Together for Girls, a partnership to end violence against children, and is a member of the UN Secretary General’s Network of Engaged Men Leaders. He has been honored by MESAB (Medical Education for South African Blacks), B’nai B’rith International, the US Fund for UNICEF, the Nyumbani Home for orphaned HIV positive children and the Dikembe Mutombo Foundation.  Cohen holds a BA and MBA from Rutgers University and previously served on the university’s board of trustees.

 

Back to top

Joseph M. Feczko, MD  Joseph M. Feczko, MD

Joseph Feczko, MD was until May 2009, senior vice president and chief medical officer (CMO) of Pfizer Inc and member of the executive leadership team with global responsibilities for all aspects of the company’s medical, regulatory, and safety activities. He is board certified (U.S.) in internal medicine and infectious diseases. Following a time in private practice, he joined Pfizer in 1982 in New York. He then worked for ten years in the United Kingdom for both Pfizer and Glaxo where his responsibilities included supervising clinical research, regulatory affairs, data management, and safety reporting. He returned to Pfizer in New York in 1996 where he held positions of increasing responsibility in clinical research, regulatory affairs, and safety, culminating in the role of CMO.

He is currently a member of the board of directors for the Foundation for the National Institutes of Health, the New York Academy of Medicine, and Research!America. In addition to serving as a member of the board of directors of Accordia Global Health Foundation, Dr. Feczko is also a member of the Technical Expert Committee for Trachoma on the International Trachoma Initiative of the Task Force for Global Health. He is currently chairman of the board of directors of Cardoz Pharmaceuticals AB (Stockholm, Sweden), a member of the board of directors of Keryx Biopharmaceuticals, Inc. (New York), a member of the supervisory board of Amsterdam Molecular Therapeutics based in The Netherlands, and a member of the board of directors of ChemoCentryx, Inc.  He was previously a member of the governing board of the Technology Strategy Board of the United Kingdom. 

Back to top

Julie L. Gerberding, MD Joseph M. Feczko, MD

Dr. Julie Gerberding joined Merck in January 2010 as President, Merck Vaccines.  She is responsible for Merck’s current portfolio of vaccines, planning for the introduction of vaccines from the company's pipeline, and accelerating efforts to broaden access to Merck’s vaccines around the world.

Dr. Gerberding served as Director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009.  In this position, she led the agency through more than 40 emergency responses to public health crises, including anthrax bioterrorism, SARS, food-borne disease outbreaks, and natural disasters.  She also advised governments around the world on urgent issues such as pandemic preparedness, AIDS, obesity, tobacco and cancer.

Dr. Gerberding received her undergraduate degree and her M.D. from Case Western Reserve University in Cleveland, Ohio.  She completed her internship and residency in internal medicine and fellowship in Clinical Pharmacology and Infectious Diseases at the University of California, San Francisco (UCSF).  Dr. Gerberding also received a Masters of Public Health at the University of California, Berkeley.  She is a member of the Institute of Medicine and a fellow of the Infectious Diseases Society of America and the American College of Physicians.

Back to top  

Ambassador Eric P. Goosby, MD

Ambassador Eric Goosby is Professor of Medicine in the Global Health Sciences program, University of California, San Francisco. In addition to seeing patients and teaching students at the UCSF-affiliated San Francisco General Hospital and Trauma Center (SFGH), Dr. Goosby is establishing a Center for Implementation Science in global health.

From 2009 to 2013, Dr. Goosby served as Ambassador at Large and U.S. Global AIDS Coordinator, overseeing the implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).  In 2012, Ambassador Goosby also led the new Office of Global Health Diplomacy at the U.S. Department of State, advancing the United States’ global health mission to improve and save lives and foster sustainability through a shared global responsibility, and implementing the Global Health Initiative’s principles and goals.  

As CEO and Chief Medical Officer of Pangaea Global AIDS Foundation, 2001-2009, he played a key role in the development and implementation of HIV/AIDS national treatment scale-up plans in South Africa, Rwanda, China and Ukraine, focusing closely on the development of successful HIV/AIDS treatment and treatment-based prevention strategies for high-risk populations.  He has over twenty-five years of experience with HIV/AIDS, ranging from early years treating patients at San Francisco General Hospital when AIDS first emerged, to engagement at the highest level of policy leadership, as the Director of the Ryan White Care Act at the U.S. Department of Health and Human Services, and later as Deputy Director of the White House National AIDS Policy Office and Director of the Office of HIV/AIDS Policy of the U.S. Department of Health and Human Services during the Clinton Administration.  Dr. Goosby has longstanding working relationships with leading multilateral organizations, including UNAIDS, the Global Fund and the World Health Organization.

Back to top

Warner C. Greene, MD, PhD  Warner C. Greene, MD, PhD

Warner C. Greene, MD, PhD is the founding director of the Gladstone Institute of Virology and Immunology (GIVI), as well as the Nick and Sue Hellmann Distinguished Professor of Translational Medicine, as a professor of medicine, microbiology and immunology at the University of California, San Francisco (UCSF), and Executive Chair of Accordia Global Health Foundation. Under his direction, GIVI has established an international reputation for excellence in the study of HIV and AIDS. Dr. Greene also serves as co-director of the federally-funded UCSF-GIVI Center for AIDS Research. The author of more than 350 scientific papers, Dr. Greene has been honored by outstanding investigator awards from the American Federation for Clinical Research and the American College of Rheumatology and has been recognized as one of the 100 most-cited scientists in the world. He is a fellow of the American Academy for the Advancement of Science, a councilor to and past president of the Association of American Physicians, and a member of the Institute of Medicine of the National Academies and the American Academy of Arts and Sciences.

Read about Dr. Greene's breakthrough HIV/AIDS discovery

Read about Dr. Greene's election to the American Academy of Arts and Sciences

Back to top  

Donald A. Holzworth, MS Donald A. Holzworth, MS

Donald A. Holzworth is executive in residence at the University of North Carolina (UNC) Gillings School of Global Public Health. He is chairman of the School’s Advisory Council and an adjunct professor of Health Policy and Management. He is the former chairman of Futures Group International and founder, chairman, and chief executive officer of Constella Group, two leading global providers of integrated approaches to improving the health and well-being of people worldwide. He was co-founder and chairman of Expression Analysis, Inc., a genomic services company spun out of Duke University Medical Center. He is co-founder of Genome Identification Group, LLC, a DNA forensics business, and co-founder of Veritas Collaborative, a specialty behavior health hospital treating adolescents with eating disorders. He is on the advisory board for Southern Capitol Ventures and Bill City Venture Partners. His public health experience led to a 2008 appointment to the Presidential Advisory Council on HIV/AIDS.

 

Back to top  

Robert MallettRobert Mallett

Robert L. Mallett is the former Executive Vice President & General Counsel, Public and Senior Markets Group, a division of United Health Group, serving as the chief legal officer for this division and managing the legal operations of its several businesses: Americhoice, Ovations, United Military and Veterans Services, and Insurance Solutions. He served as a member of the Fisk University Board of Trustees, and he is a past Chairman of the Board of Governors of Wesley Theological Seminary.  Most recently, Mr. Mallett served as the Peter P. Mullen Visiting Professor of Law at Georgetown University, and he has also served as an adjunct professor and lecturer at The Georgetown School of Law for several terms.  He has also been a lecturer and a visiting professor at the John F. Kennedy School of Government at Harvard University.

Immediately prior to joining United Health Group, Mallett served as Senior Vice President, Worldwide Policy & Public Affairs, Pfizer Inc. He also chaired Pfizer’s Intellectual Property Task Force and co-led the company’s efforts on enhancing global access to medicines. Prior to joining Pfizer in April 2001, Mallett served as Deputy Secretary of the U.S. Department of Commerce. By appointment of the President, he served on the Board of the Overseas Private Investment Corporation and was a member of the three-member Federal Steel Loan Guaranty Board. Prior to his federal executive service, Mallett was a shareholder and associate attorney at two major law firms in Washington, D.C.  He also served as City Administrator and Deputy Mayor for the District of Columbia under Mayor Sharon Pratt Kelly, and Legal Counsel to former United States Senator Lloyd Bentsen.  He has been an adjunct professor at Georgetown University’s Law Center, and was a Visiting Professor at Harvard University’s John F. Kennedy School of Government.  He served as a law clerk to the Honorable John R. Brown of the United States Court of Appeals for the Fifth Circuit.

Mallett is a member of the Council on Foreign Relations and an elected Fellow of the National Academy of Public Administrators. He is also on the boards of Fisk University and the Joint Center for Political and Economic Studies.  Mallett is a past chairman of the U.S.-South Africa Business Council, former chair of the Board of Directors of the International Trachoma Initiative, former chairman of the Board of Governors of Wesley Theological Seminary, and immediate past co-chair of the Board of Directors of Appleseed Foundation.  He is a former member of the boards of Medical Education for South African Blacks, JHPIEGO, and North General Hospital in New York’s historic Harlem community.

Mallett is a Phi Beta Kappa graduate of Morehouse College (1979) and received his law degree from Harvard University in 1982, where he was Projects Editor of the Harvard Civil Right-Civil Liberties Law Review. 

Back to top  

Henry A. McKinnell Jr, PhD, Chair of the Board   Henry A. McKinnell Jr, PhD, Chairman of the Board

Hank McKinnell retired as chairman and CEO of Pfizer Inc, the world’s largest research-based pharmaceutical company, in 2007, after originally joining the company in Tokyo in 1970. Over the years, he held positions of increasing responsibility around the world, including chief executive officer from January 2001 to August 2006.

At Accordia, Dr. McKinnell serves as a member of distinction of the Academic Alliance and chairman of the Board of Directors of Accordia. He is also a member of the boards of directors and chairman of Moody’s Corporation. He is chairman emeritus of: the Connecticut Science Center; the Business Roundtable, an association of 170 CEO’s of America’s largest companies; the Pharmaceutical Research Manufacturers Association; the Food and Drug Law Institute; and the Medical Device Manufacturers Association. Dr. McKinnell also served as vice chairman of the World Economic Forum (WEF) and as a member of the WEF Foundation Board of Trustees. He served on the President’s Advisory Council on HIV/AIDS. He also served a Director of the Medal of Honor Foundation, the Royal Shakespeare Company of America, the Japan Society, and a member of the Stanford University Graduate School of Business Advisory Council.

Dr. McKinnell holds a bachelor's degree in business from the University of British Columbia, and MBA and PhD degrees from the Stanford University Graduate School of Business. Recent honors include the Grand Cordon of the Order of the Rising Sun, Japan’s highest award given to non-royals or heads of state; the Islamic Republic of Pakistan’s Sitara-i-Eisaar award, Pakistan’s highest award for humanitarian relief; the Presidential Distinguished Service Award for contributions to health services in Uganda; the United Nations Association of the United States of America’s Global Leadership Award; the Woodrow Wilson Institute Corporate Service Award, Columbia University’s Teachers College Cleveland E. Dodge Medal for Distinguished Service to Education; Stanford University’s Graduate School of Business Arbuckle Award and Excellence in Leadership Award; and an honorary doctorate in engineering from Polytechnic University.

Back to top  

Suzanne Sande Mrlik

Zanne Sande Mrlik resides in the San Francisco Bay area where she is active as a community organizer and fundraiser, primarily in the area of education. Mrlik is the daughter of Accordia co-founder, Dr. Merle A. Sande (1939-2007), the visionary who pioneered many of the models Accordia advocates for today. Mrlik began her professional career as a civil litigator for Bronson, Bronson, and McKinnon, a major law firm in San Francisco. Over the past ten years, she has transitioned to community volunteer work in education and fundraising. Mrlik has a BA from Stanford University and a JD from Santa Clara University School of Law.

Back to top

Fred Port, MBAFred Port

Fred Port joined the Accordia Board in 2004 and currently serves as chairman of the Audit Committee and as a member of the Executive Committee. He retired as a director of Callaway Golf and President of Callaway Golf International. He served in a variety of board and senior management positions with several companies (Booz.Allen,  Santa Anita Development, Korn/Ferry International, The Palmieri Company) with emphasis on strategic change, global operations, acquisitions, revitalization, and senior management succession. In addition, he dedicates substantial effort to community activities, currently serving his 28th year with Court Appointed Special Advocates (CASA). He is Chairman of CASA's Advisory Board and has been recognized nationally as Director of the Year and by the State of California as Volunteer of the Year. Port counsels start up and mature businesses, with an emphasis on strategy, and often speaks on leadership and career development. As a cancer survivor, Port is a frequent speaker and mentor to those confronting cancer. Port is an honors graduate of the Anderson School at UCLA with an MBA degree.
 

 

Back to top

Nelson Sewankambo, MBChB, MMED, MSc, FRCP

Dr. Nelson Sewankambo is Principal of the College of Health Sciences at Makerere University in Kampala, Uganda. Fellow and President of Uganda Academy of Sciences, Fellow of The Academy of Sciences for Developing World (TWAS), External Affiliate Member of US Institute of Medicine, Member of FAIMER Board, Recipient of the Grand Silver Medal of Karoliska Institutet, and of two Honorary doctorates (from Johns Hopkins University and McMaster University). He is Chair of Initiative for Strengthening Health Research Capacity in Africa, Dr. Sewankambo was among the first scientists to publish data on AIDS in Africa, was instrumental in starting the AIDS Clinic at Mulago Hospital in Uganda, and continues to be active in HIV/AIDS research. He is currently Co-Principal Investigator (Co-PI) of the Rakai Health Sciences Program. Sewankambo was founding Director of the Clinical Epidemiology Unit, and Co-PI of the Behavioral and Qualitative Research on AIDS Prevention funded by the Canadian International Development Research Centre. He has served on numerous local and international advisory boards including the Working Party on the Ethics of Clinical Research in Developing Countries of the Nuffield Council for Bioethics, the Joint Learning Initiative, the WHO African Advisory Committee on Health and Research Development (AACHRD),  the Board of Directors of the International Clinical Epidemiology Network (INCLEN) and as a member of Council of the Global Forum for Health Research. Dr. Sewankambo is Chairman of the Infectious Diseases Institute Board.

Back to top

Stephen Sinacore

Stephen Sinacore is a co-founder and principal of Atrevida Partners, LLC, an investment advisory firm specializing in alternative asset management.

Prior to co-founding Atrevida, Sinacore served as treasurer of Citadel Investment Group, where he was responsible for the management of the firm’s balance sheet, including funding and capital allocation, and also served as interim head of the global energy portfolio.

Sinacore was previously the Chairman and Chief Executive Officer of Zurich Capital Markets Inc. (ZCM), a financial services firm specializing in structured alternative asset products and fund-of-fund management.  ZCM managed a fund of hedge funds with roughly $3.5 billion of assets.  Under a mandate from the Zurich group board, Sinacore successfully led the sale of ZCM to BNP Paribas. 

Prior to ZCM, Sinacore relocated to London, England to join RBS Greenwich Capital.  While there, Sinacore managed the firm’s global derivatives businesses, its fixed income and credit trading business in Europe and Asia, and chaired its Capital Commitment Committee.

Before that, Sinacore served at J.P. Morgan for 12 years.  Sinacore held various roles in Morgan’s London and New York offices. Sinacore was a founding member of Morgan’s global derivative sales and trading group.  Within this group, he led units trading fixed income, equity, foreign exchange and commodity derivatives.  Mr. Sinacore began his career as a precious metals trader at J. Aron & Co., a wholly owned subsidiary of Goldman Sachs & Co.

Sinacore received his B.Sc. degree in Economics and Finance from Fordham University’s College of Business Administration in 1980. He has also been a member of the President’s Council, Fordham University, Bronx, N.Y.; Senior Advisor to the Joshua House Fund, Darien, CT; Former Chairman of the Board of Sakonnet Technology, New York, N.Y.; Former Member of the Advisor Council, Massachusetts Institute of Technology, Cambridge, MA; and former member of the Advisor Council, London School of Economics, London, England. Steve is married and has three children.  

Read his Huffington Blog post. 

 

Back to top

David Greeley

As the Senior Advisor to Accordia Global Health Foundation's Board of Directors, David Greeley is responsible for assisting the Board in setting the organization's vision and increasing the visibility of Accordia and its programs.

Mr. Greeley has more than 15 years of experience with international nonprofit health and development organizations as well as more than 10 years of experience in the private sector. Immediately prior to joining Accordia, David served as Senior Vice President of External Affairs for the Global Alliance for TB Drug Development, a product development partnership working to bring new treatments to the market for tuberculosis. Before the TB Alliance, he worked in roles of increasing responsibility with leading companies and organizations such as Merck & Co. Inc., FHI 360, Population Services International, and CARE. At Merck, Mr. Greeley was responsible for the company's global HIV programs, policies, and stakeholder engagement.

Mr. Greeley has health expertise in HIV/AIDS, TB, malaria, family planning, and maternal and child health, as well as experience in public affairs, communications, policy/advocacy, resource mobilization, and program management. He has travelled to and worked in many countries in Africa, as well as Asia and Latin America, including extended stays in Burkina Faso, Niger, and the Democratic Republic of Congo. Mr. Greeley has a master’s degree in International Relations from Columbia University with a dual degree in Economic and Political Development and African Affairs.

 

Back to top